Skip to main content
. 2015 Oct 19;6(40):42963–42975. doi: 10.18632/oncotarget.5981

Figure 1. Ki-67 immunohistochemistry and labeling indices of pancreatic dysplasia in BOP-treated hamsters.

Figure 1

A–C. Representative features of Ki-67 immunohistochemical staining in the control group (A), RV treatment group (B), and AC group (C) Bars = 50 μm. RV, resveratrol; AC, apocynin. D. RV and AC significantly decreased the Ki-67 labeling index in dysplastic lesions as compared to the control group (*P < 0.05 and **P < 0.01).